The Motley Fool··James BrumleyAgios Pharma Soars 21% on FDA Fast-Track Win for Sickle Cell Drug
Agios Pharmaceuticals surges on FDA accelerated approval for mitapivat sickle cell treatment, enabling faster path to full approval despite company's ongoing losses.
AGIObiotechpharmaceutical